Sunniva Inc
CNSX:SNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (12.8), the stock would be worth CA$-17.44 (11 350% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | CA$0.16 |
0%
|
| Industry Average | 12.8 | CA$-17.44 |
-11 350%
|
| Country Average | 18.6 | CA$-25.39 |
-16 479%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CA |
S
|
Sunniva Inc
CNSX:SNN
|
6.1m CAD | -0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
804.2B USD | 39 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.4B USD | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.4B GBP | 27.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
220.1B CHF | 19.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
274.6B USD | 15 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 11.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
149.3B USD | 19.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.9B USD | 16.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 14.2 |
| Median | 18.6 |
| 70th Percentile | 29.3 |
| Max | 19 628.5 |
Other Multiples
Sunniva Inc
Glance View
Sunniva, Inc. operates as a vertically integrated cannabis company. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-01-10. The firm is a vertically integrated cannabis company operating in the cannabis market in California. The firm is focused on creating cannabis supported by its purpose-built cGMP designed glasshouse facility. The company provides its range of services through its wholly owned subsidiary CP Logistics, LLC.
